pyrazines has been researched along with Coronary Restenosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LJ; Ding, S; Feng, Y | 1 |
| Ahn, BY; Cho, BJ; Choi, SH; Jang, HC; Kang, SM; Kim, YB; Lim, S; Park, HS; Park, KS; Shin, H; Yoon, JW | 1 |
| Chen, L; Chen, Z; Ding, S; Feng, Y; Ma, G; Shen, C | 1 |
| Chen, LJ; Chen, Z; Ding, S; Feng, Y; Ma, GS; Shen, CX | 1 |
4 other study(ies) available for pyrazines and Coronary Restenosis
| Article | Year |
|---|---|
[The efficacy of tetramethylpyrazine-eluting stents on inhibiting neointima formation in porcine coronary arteries].
Topics: Animals; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Double-Blind Method; Drug-Eluting Stents; Pyrazines; Swine; Tunica Intima | 2008 |
Effect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in rats.
Topics: Adiponectin; Administration, Oral; Animals; Blood Glucose; C-Reactive Protein; Carotid Arteries; Carotid Artery Injuries; Chemokine CCL2; Coronary Restenosis; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Plasminogen Activator Inhibitor 1; Pyrazines; Rats; Rats, Inbred OLETF; Sitagliptin Phosphate; Triazoles; Tumor Necrosis Factor-alpha; Tunica Intima | 2012 |
Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
Topics: Animals; Apoptosis; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Endothelium, Vascular; Hyperplasia; Methylmethacrylate; Platelet Aggregation Inhibitors; Polyglycolic Acid; Polymers; Proliferating Cell Nuclear Antigen; Pyrazines; Stents; Swine; Tunica Intima | 2007 |
Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
Topics: Animals; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Kidney; Liver; Platelet Aggregation Inhibitors; Pyrazines; Swine; Thrombosis; Time Factors; Tunica Intima | 2008 |